$UPXI

UPEXI, INC. (UPXI): Results of Operations and Financial Condition

UPEXI, INC. (UPXI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Upexi Reports Financial Results for Fiscal Year Ended June 30, 2026 Digital Asset Revenue Totaled $17.4 Million for Fiscal Year 2026 Solana Treasury Totaled Approximately 2.34 Million SOL as of June 30, 2026 Conference Call Scheduled for Today, September 17, 2026, at

Original reporting
Published Sep 17, 2026, 9:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 9:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$UPXI
Bearish
high confidence
Mentioned
$UPXI
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$UPXIBearishHigh
01

Why it matters

The earnings release provides the first public view of FY 2026 performance, revealing large unrealized crypto losses and balance‑sheet improvements.

02

Market read

Primary earnings disclosure for a crypto‑exposed public company; likely to move the stock and influence sentiment toward similar assets.

03

What to watch

Staked SOL yields and potential future appreciation are not reflected in current loss figures.

Relevance 7/10Novelty 8/10Timing: post‑earnings release today

Background

Upexi is a Nasdaq‑listed digital‑asset treasury company focused on Solana, also operating consumer brands.

Company-level read

Ticker impact

$UPXIBearishHigh confidence
Context

Upexi disclosed FY 2026 results with revenue $25M, net loss $246.1M and 2.34M SOL held.

Expected impact

Potential short-term decline, with volatility as investors reassess Solana exposure.

Evidence & confidence

First‑report 8‑K earnings with material loss and crypto exposure; market will react to loss magnitude and balance sheet changes.

Market effects

Highlights risk in digital‑asset treasury models and may affect other Solana‑focused firms.

US investors with exposure to crypto‑linked stocks may see heightened scrutiny.

Signals broader market sensitivity to crypto asset volatility.

Counterpoint

Balance sheet de‑leveraging and growing cash could enable a turnaround if Solana price recovers.

Key entities

  • Upexi, Inc.

    NASDAQ: UPXI, digital‑asset treasury and consumer brands owner.

  • Allan Marshall

    Chief Executive Officer of Upexi.

Related articles

$UPXIMed

Upexi Partners with Blueprint to Stake Solana Treasury Assets

Upexi, Inc. (NASDAQ: UPXI) said it partnered with Blueprint, an institutional Solana staking/infrastructure affiliate of Hivemind Capital Partners, to stake a portion of its Solana (SOL) holdings using Blueprint’s institutional Solana validator. Upexi said it aims to grow its SOL treasury and support Solana network decentralization; it reported holding over 2 million SOL.

$HCWCLow

HEALTHY CHOICE WELLNESS CORP. (HCWC): Results of Operations and Financial Condition

HEALTHY CHOICE WELLNESS CORP. (HCWC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS OF HOST DIGITAL INFRASTRUCTURE LLC The following discussion should be read together with Host Digital Infrastructure LLC’s (the “Company”, “we”, “our” and “us”) financial statements

$AMZNMedAI 8/10

Amazon’s Jassy Bets on Trillion-Dollar AWS Future as AI Demand Outruns Even $220 Billion Spend

Amazon CEO Andy Jassy forecasted AWS could generate $1 trillion in annual revenue, citing strong AI demand. AWS's current annualized revenue is $169 billion. Amazon raised its 2026 capital expenditure forecast to $220 billion, up from $200 billion, to meet infrastructure needs. Jassy noted supply shortages will persist despite increased spending, with AI-specific revenue run rate exceeding $25 billion.

$MDTHighAI 8/10

Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?

Medtronic (MDT) shares are down 3% this year, but the company's Hugo robotic-assisted surgery system is gaining market share. The FDA approved Hugo for urological procedures, and Medtronic submitted new filings for broader use. Q1 2027 revenue was $9.8B, up 13.7% YoY, with EPS of $1.14, up 40.7%. The company raised full-year guidance and is on track to become a Dividend King. Medtronic's dividend yield is 3.06%, and it is expanding in cardiac and spinal technologies.

$NBISHighAI 8/10

Backed Nebius Group Stock Skyrocketed Thursday Morning

Nebius Group (NASDAQ: NBIS) stock rose 11.2% after announcing a 20% price increase for on-demand GPU compute services starting next month. The company reported a 454% year-over-year revenue growth to $582 million in Q2, with expectations of $3.2 billion for the full year. Nvidia (NASDAQ: NVDA), which holds a 9.3% stake in Nebius, is a key partner.

$FNVHighAI 8/10

Franco-Nevada Nears All-Time Highs After Record Revenue Growth

Franco-Nevada (FNV) reported record revenue of $580.9M in Q2 FY2026, up 57.3% YoY, with 132,405 gold equivalent ounces sold. Adjusted net income rose 46% to $349.2M. Shares are up 27% YTD, supported by institutional demand and strong fundamentals, including 63.6% sales growth over one year and an 11.3% EPS increase expected this year.